Effects of aloe vera supplementation in subjects with prediabetes/metabolic syndrome

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 1, 2013, Pages 35-40

  Devaraj, Sridevi ^a   Yimam, Mesfin ^b   Brownell, Lidia A ^b   Jialal, Ishwarlal ^c   Singh, Sital ^c   Jia, Qi ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b Unigen Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AC 952; ALOE VERA EXTRACT; C REACTIVE PROTEIN; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ISOPROSTANE DERIVATIVE; LIPID; PLACEBO; UNCLASSIFIED DRUG; UP 780;

ADULT; ALOE VERA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ALOE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLACEBOS; PLANT EXTRACTS; PREDIABETIC STATE;

EID: 84872832551     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0066     Document Type: Article

References (18)

1. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J AmColl Cardiol 2012;59:635-643.
2. Alberti KG, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
3. Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112: 2735-2752.
4. Ajabnoor MA. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol 1990;28: 215-220.
5. Ghannam N, Kingston M, Al-Meshaal IA, et al. The antidiabetic activity of aloes: Preliminary clinical and experimental observations. Horm Res 1986;24:288-294.
6. Rajasekaran S, Sivagnanam K, Ravi K, et al. Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. J Med Food 2004;7:61-66.
7. al-Awadi F, Fatania H, Shamte U. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res 1991;18:163-168.
8. Parihar MS, Chaudhary M, Shetty R, et al. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: Prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 2004;11: 397-402.
9. Bolkent S, Akev N, Ozsoy N, et al. Effect of Aloe vera (L.) Burm. fil. leaf gel and pulp extracts on kidney in type-II diabetic rat models. Indian J Exp Biol 2004;42:48-52.
10. Can A, Akev N, Ozsoy N, et al. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004;27:694-698.
11. Rajasekaran S, Ravi K, Sivagnanam K, et al. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol 2006;33: 232-237.
12. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, et al. Antidiabetic activity of Aloe vera L juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996;3:241-243.
13. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, et al. Antidiabetic activity of Aloe vera L juice.I. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996;3:245-248.
14. Huseini HF, Kianbakht S, Hajiaghaee R, et al. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Planta Med 2012;78:311-316.
15. Devaraj S, Hirany SV, Burk RF, et al. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem. 2001;47:1974-1979.
16. Vega-Lopez S, Devaraj S, Jialal I. Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J Investig Med 2004;2:24-32.
17. Tsai IJ, Croft KD, Mori TA, et al. 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction. Free Radic Biol Med 2009;46:263-270.
18. Rajasekaran S, Sivagnanam K, Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 2005;57:90-96.